Outcomes of ultrasound-guided foam sclerotherapy for varicose veins of the lower extremities: Single center experience

Dermatologic Surgery

Volumn 37, Issue 6, 2011, Pages 810-811

  Raymond Martimbeau, Pauline ^a  

^a Dallas Non Invasive Vascular Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL; TETRADECYL SULFATE SODIUM; SCLEROSING AGENT;

COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FLUOROSCOPY; FOAM SCLEROTHERAPY; HUMAN; HYPERPIGMENTATION; INTERMETHOD COMPARISON; LEG VARICOSIS; MIGRAINE; NOTE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RECURRENT DISEASE; SAPHENOUS VEIN; SCLEROTHERAPY; THORAX PAIN; THROMBOPHLEBITIS; TREATMENT OUTCOME; ULTRASOUND; VEIN DIAMETER; VISUAL DISORDER; ENDOSCOPIC ECHOGRAPHY; VARICOSIS;

HUMANS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 79959831616     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01996..x     Document Type: Note

References (11)

1. Palm MD, Guiha IC, Goldman MP. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse events. Dermatol Surg 2010;36:1026-33.
2. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, et al. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5. (Pubitemid 38009913)
3. Raymond-Martimbeau P. Transient adverse events positively associated with patent foramen ovale after ultrasound-guided foam sclerotherapy. Phlebology 2009;24:114-9.
4. Kikuchi M, HosoKawa K. Visualized sclerotherapy of varicose veins. Dermatol Surg 2010;36:1050-5.
5. Raymond-Martimbeau P. A randomized clinical trial comparing the sclerosing and side effects of foam versus liquid formula for sclerotherapy of primary varicose veins. In: American College of Phlebology. Syllabus & Scientific Abstracts of the UIP World Congress Chapter Meeting. 27-31 August 2003, San Diego, CA. 2003, p. 138
6. Guex JJ. Complications of sclerotherapy: an update. Dermatol Surg 2010;36:1056-63.
7. Hamahata A, Yamaki T, Sakurai H. Outcomes of ultrasound-guided foam sclerotherapy for varicose veins of the lower extremities: a single center experience. Dermatol Surg 2011;37: 804-9.
8. Stucker M, Kobus S, Altmeyer P, Reich-Schupke S. Review of published information on foam sclerotherapy. Dermatol Surg 2010;36:983-92.
9. Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy, April, 4-6, 2003, Tegernsee, Germany. Dermatol Surg 2004;30:709-17.
10. Breu FX, Guggenbichler S, Wollmann JC. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa 2008;37:90-5.
11. Peterson JD, Goldman MP. An investigation into the influence of various gases and concentrations of sclerosants on foam stability. Dermatol Surg 2010;36:1-6.